Searching…
BioNTech develops mRNA cancer immunotherapies, next-generation immunomodulators and targeted therapies in oncology, and vaccines against infectious diseases.
BioNTech es una empresa biotecnológica que desarrolla terapias innovadoras para el cáncer y enfermedades infecciosas, combinando ciencia avanzada con un enfoque transformador.
Explore BioNTech's unique pipeline of innovative therapies and vaccines, including mRNA cancer immunotherapies, next-generation immunomodulators, targeted therapies and infectious disease vaccines.
Discover BioNTech’s mRNA platforms, designed to revolutionize treatments in oncology and infectious diseases. Leveraging advanced mRNA technology, BioNTech develops personalized treatment approaches and vaccines that ...
BioNTech is a global biopharmaceutical company pioneering novel investigative therapies for cancer and infectious diseases. We are committed to transforming how cancer is treated. With more than 15 years of immunology...
At BioNTech, we are dedicated to improving the health of people worldwide by harnessing the full potential of the human immune system to develop drugs for diseases with high or unmet medical needs. In pursuit of our v...
Sep 23, 2025 · The Investor Relations website contains information about BioNTech's business for stockholders, potential investors, and financial analysts.
BioNTech SE (/ biːˈɒntɛk / bee-ON-tek; or / baɪˈɒntɛk / bye-ON-tek[3] short for Biopharmaceutical New Technologies) is a German multinational biotechnology company headquartered in Mainz that develops immunotherapies ...
Discover how BioNTech is pioneering novel medicines for cancer and infectious diseases. Learn more about our clinical trials, the importance of participation, and how to get involved in advancing global health.
BioNTech SE （德語發音： [ˈbaɪɒnˌtek]； NASDAQ： BNTX）被译为 生物新技术公司 或 拜恩泰科[2][3]，是一家位于 德国 美因茨 的生物技术公司，主要業務為开发和生产针对特定患者的治疗严重疾病的有效 免疫治疗 [1]。
